Genes in panel
Regions in panel
Prev Next

Intellectual disability

Gene: GNAI2

Green List (high evidence)

GNAI2 (G protein subunit alpha i2)
EnsemblGeneIds (GRCh38): ENSG00000114353
EnsemblGeneIds (GRCh37): ENSG00000114353
OMIM: 139360, Gene2Phenotype
GNAI2 is in 3 panels

4 reviews

Sarah Leigh (Genomics England Curator)

Green List (high evidence)

The rating of this gene has been updated to green following NHS Genomic Medicine Service approval.
Created: 24 Feb 2025, 6:15 p.m. | Last Modified: 24 Feb 2025, 6:15 p.m.
Panel Version: 8.97

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Dmitrijs Rots (Children's Clinical University Hospital)

Green List (high evidence)

PMID: 39298586 showed 20 case with "multiorgan dysfunction, with a spectrum of birth defects involving brain, endocrine, skeletal, and other systems. Prominent immune dysregulation resulted from increased infection susceptibility—caused by impaired GPCR signaling for migration of T cells and neutrophils—and life-threatening autoimmunity with T cell hyperresponsiveness." and functional work.
Created: 18 Oct 2024, 12:32 p.m. | Last Modified: 18 Oct 2024, 12:32 p.m.
Panel Version: 7.61

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Immunodefficiency with multisystemic presentation

Publications

Mode of pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

Arina Puzriakova (Genomics England Curator)

I don't know

Comment on list classification: There is sufficient evidence to promote this to Green at the next GMS panel update. Multiple individuals reported with heterozygous variants supported by functional studies. In PMID:39298586 neurodevelopmental delay in early childhood was reported in 68% of cases, which progressed to ID as patients became older in 53%. Overall patients present with a highly variable phenotype that would be suited to the R27 Paediatic disorders super panel - inclusion on the ID panel would feed into R27.
Created: 15 Nov 2024, 10:16 a.m. | Last Modified: 15 Nov 2024, 10:16 a.m.
Panel Version: 8.34
Ham et al. (2024) (PMID: 39298586) - 20 individuals from 18 unrelated families with heterozygous GOF missense variants in GNAI2 and highly heterogenous clinical presentations. Most commonly observed was disruption of the immune system, with almost 90% of cases exhibiting recurrent, unusual, and/or severe infections. Other features include birth defects, growth abnormalities, neurodevelopmental delay progressing to ID at later stages, brain structural abnormalities and various dysmorphic features. Authors dubbed the syndromic disorder with the acronym MAGIS - Midline malformations of the brain,
Anterior hypopituitarism, Growth retardation, Immunodeficiency/immunodysregulation, Skeletal
abnormalities.
Created: 15 Nov 2024, 10:04 a.m. | Last Modified: 15 Nov 2024, 10:04 a.m.
Panel Version: 8.30
Lecoquierre et al. (2019) (PMID: 31036916) identified a de novo GNAI2 missense variant (p.Arg179His) in a proband with a syndromic developmental disorder. They highlighted that a distinct substitution of the same residue (p.Arg179Cys) had also been reported in the denovo-db database, in a patient with a developmental disorder. However, details regarding the exact phenotype are limited and therefore further characterisation is warranted. No function analysis was undertaken to validate the implication on GNAI2.

Hamada et al. (2017) (PMID: 27787898) reported a de novo heterozygous missense mutation (p.Ala227Val) in an individual with periventricular nodular heterotopia, seizures, and intellectual disability. Function studies in knockdown mice showed delayed radial migration of excitatory neurons during corticogenesis. Mice displayed abnormal social behaviours, altered anxiety, and learning deficits.

Not associated with the phenotype in OMIM or G2P.
Created: 8 Jul 2020, 8:08 a.m. | Last Modified: 8 Jul 2020, 8:08 a.m.
Panel Version: 3.156

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Syndromic developmental disorder

Publications

Zornitza Stark (Australian Genomics)

I don't know

Two individuals reported, some functional data.
Sources: Literature
Created: 23 Apr 2020, 4:27 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Syndromic intellectual disability

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • NHS GMS
Phenotypes
  • Syndromic intellectual disability
OMIM
139360
Clinvar variants
Variants in GNAI2
Penetrance
None
Publications
Mode of Pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
Panels with this gene

History Filter Activity

25 Feb 2025, Gel status: 3

Removed Tag

Sarah Leigh (Genomics England Curator)

Tag Q3_24_promote_green was removed from gene: GNAI2.

24 Feb 2025, Gel status: 3

Added New Source, Added New Source, Status Update

Sarah Leigh (Genomics England Curator)

Source NHS GMS was added to GNAI2. Source Expert Review Green was added to GNAI2. Rating Changed from Amber List (moderate evidence) to Green List (high evidence)

15 Nov 2024, Gel status: 2

Entity classified by Genomics England curator

Arina Puzriakova (Genomics England Curator)

Gene: gnai2 has been classified as Amber List (Moderate Evidence).

15 Nov 2024, Gel status: 2

Set mode of pathogenicity

Arina Puzriakova (Genomics England Curator)

Mode of pathogenicity for gene: GNAI2 was changed from Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

15 Nov 2024, Gel status: 2

Set mode of pathogenicity

Arina Puzriakova (Genomics England Curator)

Mode of pathogenicity for gene: GNAI2 was changed from Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

15 Nov 2024, Gel status: 2

Set mode of pathogenicity

Arina Puzriakova (Genomics England Curator)

Mode of pathogenicity for gene: GNAI2 was changed from None to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

15 Nov 2024, Gel status: 2

Set publications

Arina Puzriakova (Genomics England Curator)

Publications for gene: GNAI2 were set to 31036916; 27787898

15 Nov 2024, Gel status: 2

Added Tag

Arina Puzriakova (Genomics England Curator)

Tag Q3_24_promote_green tag was added to gene: GNAI2.

24 Jul 2020, Gel status: 2

Entity classified by Genomics England curator

Arina Puzriakova (Genomics England Curator)

Gene: gnai2 has been classified as Amber List (Moderate Evidence).

23 Apr 2020, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Zornitza Stark (Australian Genomics)

gene: GNAI2 was added gene: GNAI2 was added to Intellectual disability. Sources: Literature Mode of inheritance for gene: GNAI2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: GNAI2 were set to 31036916; 27787898 Phenotypes for gene: GNAI2 were set to Syndromic intellectual disability Review for gene: GNAI2 was set to AMBER